摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 503842-83-9

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
503842-83-9
化学式
C20H23ClN2O
mdl
——
分子量
342.868
InChiKey
IYVATTPNNWCMHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.77
  • 重原子数:
    24.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    25.24
  • 氢给体数:
    0.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    N-溴代丁二酰亚胺(NBS)四(三苯基膦)钯sodium carbonate 作用下, 以 乙二醇二甲醚N,N-二甲基甲酰胺 为溶剂, 生成 1-(2-Chlorophenyl)-2-(4-chlorophenyl)-5-cyclohexyl-3-methyl-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridin-4-one
    参考文献:
    名称:
    Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives
    摘要:
    A series of pyrrolopyridinones was designed and synthesized as constrained analogs of the pyrazole CB-1 antagonist rimonabant. Certain examples exhibited very potent hCB-1 receptor binding affinity and functional antagonism with Ki and Kb values below 10 nM, and with high selectivity for CB-1 over CB-2 (> 100-fold). A representative analog was established to cause significant appetite suppression and reduction in body weight gain in industry-standard rat models used to develop new therapeutics for obesity. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.10.095
  • 作为产物:
    描述:
    参考文献:
    名称:
    Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives
    摘要:
    A series of pyrrolopyridinones was designed and synthesized as constrained analogs of the pyrazole CB-1 antagonist rimonabant. Certain examples exhibited very potent hCB-1 receptor binding affinity and functional antagonism with Ki and Kb values below 10 nM, and with high selectivity for CB-1 over CB-2 (> 100-fold). A representative analog was established to cause significant appetite suppression and reduction in body weight gain in industry-standard rat models used to develop new therapeutics for obesity. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.10.095
点击查看最新优质反应信息